Mr. Zynn is the President and CEO of ID Connect. He is a proven leader with over 30 years of experience guiding healthcare services and telehealth companies through the growth stage to success. Dave brings organizational development, growth strategy and leadership to ID Connect.

Dave is also an advisor to his alma maters school of business, a member of a for-profit board of directors and is active with the Folds of Honor organization. He also enjoys sports, travel and is a longtime foodie.

As a Senior Executive with a progressive career in sales and business development, David Keene comes to ID Connect, having led companies in the medical device, healthcare IT, and life sciences fields specializing in go to market strategies for new and emerging businesses. Keene has a background in workflow management and process improvement. At ID Connect, he is the Senior Vice President responsible for Sales, Marketing, and Business Development.

Prior to joining ID Connect, he was the North America Sales Leader for IV Solutions with Omnicell and Aesynt, creating a new business that consistently exceeded benchmarks year over year while improving customer success metrics. Earlier in his career, he was a Senior Sales Leader for McKesson for over a decade.

Originally from Mashpee, Massachusetts, Keene is a graduate of Boston College, Carroll School of Management. He enjoys golfing and water sports. He has two young adult children and currently resides in Jupiter, Florida, with his wife Christine but still considers Cape Cod home.

As the CTO of ID Connect, Ben leads development and implementation, including strategic and feature prioritization of our products.

Prior to joining ID Connect, Ben served as an executive team member for Syneos Health Managed Markets in charge of Integrated Strategic and Creative Services for hospital and market access initiatives with a focus on technology, operations, media, planning, and creative. During this time Ben acted as a client liaison for technical and strategic matters, and was hands-on in the creation, branding, and development of pharmaceutical services and the products themselves. Before joining Syneos Health, Ben worked with companies where he helped evolve a relationship marketing business into a more digital focused entity through both customer strategy and application development, and was involved in the design and development of one of the first online payroll applications.

In addition, Ben kicked off his technology career as one of three individuals launching, building, and managing an Internet Service Provider leading to the company’s acquisition.

As ID Connect’s Chief Financial Officer, Riaan is responsible for the financial and business operations of the organization, as well as strategic business development activities.

Most recently, Riaan was one of the co-founders and Chief Operating Officer of ILÚM Health Solutions which was acquired by ID Connect in 2020. Riaan also spent over 21 years with Merck & Co., Inc. as Executive Director in Business Development, Strategy & Operations, which included managing the execution of strategic corporate initiatives from incubation to full scale operations as well as sourcing and closing multiple business development transactions. He served as a board member on invested entities and supported multiple exits and divestitures. Riaan started his career as an external auditor at EY.

Riaan is a Chartered Accountant (CA) and holds a Honors Bachelor of Accounting Science from the University of South Africa and a Bachelor of Commerce in Accountancy from the University of Pretoria. He was also a Certified Supply Chain Professional (CSCP) from the American Production and Inventory Control Society (APICS). He enjoys spending time outdoors and loves to cook over an open fire.

Paul joined Infectious Disease Connect (IDC) as the Chief Strategy Officer after the acquisition of ILUM health solutions, where he was the CEO. Paul’s current responsibilities include leading all facets of the Public Health Surveillance business as well as developing, communicating and executing IDC’s core strategy. As part of this role, he is responsible for facilitating and driving key strategic initiatives from inception to execution.

Prior to IDC and ILUM, Paul was with Merck & Co inc. for 22 years where he held several leadership positions during his tenure, including; Global Brand Leader – Infectious Diseases; Business Operations Director; Franchise Leader and European Marketing Director.

In these roles, Paul has gained leadership experience both in the US and abroad and has held both strategic and operational positions. Paul has focused on infectious disease, antimicrobial stewardship and precision medicine from a global perspective long before the topic was a focus. He has led teams that have implemented Antimicrobial Stewardship Programs in many countries around the world, most notably Russia, India, South Africa and Colombia. It is from this global perspective that Paul understands the critical importance of focusing on patient and hospital outcomes.

Paul holds an MBA from Oxford Brookes University in the United Kingdom.